The study represents the first long-term, large-scale, real-world trial of the blockbuster drug, researchers say
Regulatory uncertainty persists, as the FDA has yet to finalize its guidance on GLP-1 biosimilars, creating a timing risk for follow-on entrants
For those feeling like their results are slower than expected, this feature provides context and reassurance
Recent Advances in antioxidant cosmeceutical topical delivery
In clinical settings, peptide therapies are often administered via injection, although oral formulations are under investigation to improve accessibility and adherence
Among the most well-known and studied effects of GLP-1 is its impact on the pancreatic islet, where the activation of GLP-1-associated signaling pathways results in increased insulin secretion and reduced glucagon production